Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Becton, Dickinson and Company (BD) is a medical technology company that manufactures and sells medical devices, reagents and instrument systems for life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry and general public. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; prefillable drug delivery systems; respiratory ventilation and diagnostics equipment and consumables; products for the safe collection and transport of diagnostics specimens; instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infectionsand cancers and various clinical research tools. The company through BD Technologies conducts research and development activities to improve manufacturing and process methods. The company sells its in the Americas, Europe, the Middle East, Africa, Asia Pacific. BD is headquartered in New Jersey, the US. Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. 3

- Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH511D Number of Pages : 85 Report Format : PDF 4

Publisher Information : 5

Table Of Contents for Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 4List of Figures 6Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7Becton, Dickinson and Company, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 8Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 10Becton, Dickinson and Company, Medical Devices Deals, 2010 to YTD 2016 11Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 13Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deal Details 17Venture Financing 17GenCell Biosystems Raises US$3.5 Million In Seed Financing Round 17Sirigen Secures US$3 Million In Venture Financing 18Sirigen Secures US$6.13 Million In Venture Financing 20Accuri Cytometers Secures US$6 Million In Series E Preferred Stock Financing Round 22Private Equity 23Apax Partners to Acquire 50.1% Stake in Respiratory Solutions Business of Becton, Dickinson 23CareFusion Reportedly Elicits Acquisition Interest From Private Equity Firms 24Partnerships 25Selah Genomics, Greenville Health, DecisionQ and Becton Dickinson Enter into Agreement 25GenCell Biosystems To Enter Into Agreement With Fiocruz, Institute Of Molecular Biology Of Parana And Immunobiological Technology Institute To Develop Clinical Screening Systems 26Sartorius Stedim Biotech Enters Into Co-Development Agreement With BD Diagnostic 27NanoString Technologies And BD Biosciences Enter Into Agreement To Develop Single Cell Isolation And Analysis Workflow 28TCGRx Enters Into Co-Marketing Agreement With CareFusion For Medication Delivery Solutions 30CareFusion Enters Into Distribution Agreement With ResMed 31SANYO North America Enters Into Co-Promotion Agreement With BD Biosciences 32Accuri Cytometers Enters Into Co-Marketing Agreement With ebioscience 33Bruker Daltonics And KIESTRA Enter Into Co-Marketing Agreement 34Licensing Agreements 35Advanced Inhalation Therapies Enters into Licensing Agreement with CareFusion 35BD Diagnostic Systems Enters Into Licensing Agreement With Lonza Group 36Fate Therapeutics Enters Into Licensing Agreement With Becton, Dickinson 37CareFusion Enters Into Licensing Agreement With Healthpoint 39Eurogentec Enters Into Licensing Agreement With BD Diagnostics 40Caliper Life Sciences Enters Into Licensing Agreement With BD Biosciences 41Equity Offering 42Becton, Dickinson Files Registration Statement For Public Offering Of Securities 42Debt Offering 43Becton, Dickinson Raises USD1.2 Billion in Public Offering of 4.685% Notes Due 2044 43Becton, Dickinson Raises USD1.75 Billion in Public Offering of 3.734% Notes Due 2024 45Becton, Dickinson Raises USD750 Million in Public Offering of Floating Rate Notes Due 2016 47Becton, Dickinson Raises USD1.25 Billion in Public Offering of 2.675% Notes Due 2019 49Becton, Dickinson Raises USD1.25 Billion in Public Offering of 1.8% Notes Due 2017 51CareFusion Raises USD300 Million in Public Offering of Notes Due 2044 53CareFusion Raises USD300 Million in Private Placement of Notes Due 2017 55CareFusion Raises USD400 Million in Public Offering of Notes Due 2024 57CareFusion Completes Private Placement Of Notes Due 2023 For US$300 Million 59Becton, Dickinson Completes Public Offering Of Notes Due 2016 For US$500 Million 60Becton, Dickinson Completes Public Offering Of Notes Due 2021 For US$1 Billion 61Becton, Dickinson and Company Completes Underwritten Public Offering Of Senior Unsecured Notes Due 2040 For US$300 Million 63Becton, Dickinson Completes Underwritten Public Offering Of Senior Unsecured Notes Due 2020 For US$700 Million 64Asset Transactions 65Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 65eResearchTechnology Acquires Research Services Division From CareFusion 66Acquisition 68BD Acquires CRISI Medical Systems 68Becton, Dickinson Acquires GenCell Biosystems 69Becton, Dickinson Acquires Sirigen, Developer Of Polymer Dyes 70Becton, Dickinson Acquires KIESTRA, Provider Of Lab Automation Solutions 72CareFusion Completes Acquisition Of Medegen From Nautic Partners 73Becton, Dickinson and Company - Key Competitors 75Key Employees 76Locations And Subsidiaries 78Head Office 78Other Locations & Subsidiaries 78Appendix 85Methodology 85About GlobalData 85Contact Us 85Disclaimer 85 6

List Of Tables in Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Key Facts, 2015 1 Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7 Becton, Dickinson and Company, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 8 Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9 Becton, Dickinson and Company, Deals By Therapy Area, 2010 to YTD 2016 10 Becton, Dickinson and Company, Medical Devices Deals, 2010 to YTD 2016 11 Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 13 GenCell Biosystems Raises US$3.5 Million In Seed Financing Round 17 Sirigen Secures US$3 Million In Venture Financing 18 Sirigen Secures US$6.13 Million In Venture Financing 20 Accuri Cytometers Secures US$6 Million In Series E Preferred Stock Financing Round 22 Apax Partners to Acquire 50.1% Stake in Respiratory Solutions Business of Becton, Dickinson 23 CareFusion Reportedly Elicits Acquisition Interest From Private Equity Firms 24 Selah Genomics, Greenville Health, DecisionQ and Becton Dickinson Enter into Agreement 25 GenCell Biosystems To Enter Into Agreement With Fiocruz, Institute Of Molecular Biology Of Parana And Immunobiological Technology Institute To Develop Clinical Screening Systems 26 Sartorius Stedim Biotech Enters Into Co-Development Agreement With BD Diagnostic 27 NanoString Technologies And BD Biosciences Enter Into Agreement To Develop Single Cell Isolation And Analysis Workflow 28 TCGRx Enters Into Co-Marketing Agreement With CareFusion For Medication Delivery Solutions 30 CareFusion Enters Into Distribution Agreement With ResMed 31 SANYO North America Enters Into Co-Promotion Agreement With BD Biosciences 32 Accuri Cytometers Enters Into Co-Marketing Agreement With ebioscience 33 Bruker Daltonics And KIESTRA Enter Into Co-Marketing Agreement 34 Advanced Inhalation Therapies Enters into Licensing Agreement with CareFusion 35 BD Diagnostic Systems Enters Into Licensing Agreement With Lonza Group 36 Fate Therapeutics Enters Into Licensing Agreement With Becton, Dickinson 37 7

CareFusion Enters Into Licensing Agreement With Healthpoint 39 Eurogentec Enters Into Licensing Agreement With BD Diagnostics 40 Caliper Life Sciences Enters Into Licensing Agreement With BD Biosciences 41 Becton, Dickinson Files Registration Statement For Public Offering Of Securities 42 Becton, Dickinson Raises USD1.2 Billion in Public Offering of 4.685% Notes Due 2044 43 Becton, Dickinson Raises USD1.75 Billion in Public Offering of 3.734% Notes Due 2024 45 Becton, Dickinson Raises USD750 Million in Public Offering of Floating Rate Notes Due 2016 47 Becton, Dickinson Raises USD1.25 Billion in Public Offering of 2.675% Notes Due 2019 49 Becton, Dickinson Raises USD1.25 Billion in Public Offering of 1.8% Notes Due 2017 51 CareFusion Raises USD300 Million in Public Offering of Notes Due 2044 53 CareFusion Raises USD300 Million in Private Placement of Notes Due 2017 55 CareFusion Raises USD400 Million in Public Offering of Notes Due 2024 57 CareFusion Completes Private Placement Of Notes Due 2023 For US$300 Million 59 Becton, Dickinson Completes Public Offering Of Notes Due 2016 For US$500 Million 60 Becton, Dickinson Completes Public Offering Of Notes Due 2021 For US$1 Billion 61 Becton, Dickinson and Company Completes Underwritten Public Offering Of Senior Unsecured Notes Due 2040 For US$300 Million 63 Becton, Dickinson Completes Underwritten Public Offering Of Senior Unsecured Notes Due 2020 For US$700 Million 64 Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 65 eresearchtechnology Acquires Research Services Division From CareFusion 66 BD Acquires CRISI Medical Systems 68 Becton, Dickinson Acquires GenCell Biosystems 69 Becton, Dickinson Acquires Sirigen, Developer Of Polymer Dyes 70 Becton, Dickinson Acquires KIESTRA, Provider Of Lab Automation Solutions 72 CareFusion Completes Acquisition Of Medegen From Nautic Partners 73 Becton, Dickinson and Company, Key Competitors 75 Becton, Dickinson and Company, Key Employees 76 Becton, Dickinson and Company, Other Locations 78 Becton, Dickinson and Company, Subsidiaries 79 8

List Of Figures, Charts and Diagrams in Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1 Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1 Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1 Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1 Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7 Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 8 Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9 Becton, Dickinson and Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 10 Becton, Dickinson and Company, Medical Devices Deals, 2010 to YTD 2016 11 9

How to Buy... Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 10